Bayer AG is no longer planning to sell its diabetes unit, Joerg Reinhardt, Chief Executive Officer of Bayer HealthCare AG, said. Joerg Reinhardt said, "We are keeping it. We evaluated different options and we came to the conclusion that we continue to be the best owner.”